Revolution Medicines, Inc.·4

Mar 3, 9:07 PM ET

Anders Jack 4

4 · Revolution Medicines, Inc. · Filed Mar 3, 2026

Insider Transaction Report

Form 4
Period: 2026-03-01
Anders Jack
Chief Financial Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-01+20,200128,265 total
  • Award

    Stock Option (Right to Buy)

    [F2]
    2026-03-01+45,40045,400 total
    Exercise: $102.02Exp: 2036-02-28Common Stock (45,400 underlying)
Footnotes (2)
  • [F1]Includes 62,538 restricted stock units.
  • [F2]One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2026 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Signature
/s/ Jack Anders|2026-03-03

Documents

1 file
  • 4
    form4.xmlPrimary